| Propanoate metabolism |
2.07 |
0.00e+0 |
30/34 (88.24%) |
DLD;ALDH6A1;SUCLG2;...
|
| Valine, leucine and isoleucine degradation |
1.89 |
2.31e-2 |
42/48 (87.5%) |
DLD;ALDH2;ALDH6A1;...
|
| Nitrogen metabolism |
1.84 |
3.07e-2 |
16/17 (94.12%) |
CPS1;CA4;CA2;...
|
| Fatty acid degradation |
1.81 |
3.00e-2 |
40/43 (93.02%) |
ALDH2;ALDH3A2;ACAT1;...
|
| Histidine metabolism |
1.79 |
3.32e-2 |
16/22 (72.73%) |
ALDH2;ALDH3A2;ALDH3A1;...
|
| Proximal tubule bicarbonate reclamation |
1.79 |
2.77e-2 |
21/23 (91.3%) |
SLC4A4;ATP1B3;CA4;...
|
| DNA replication |
1.76 |
2.90e-2 |
34/36 (94.44%) |
RFC2;RFC5;MCM4;...
|
| Thyroid cancer |
1.72 |
4.04e-2 |
36/37 (97.3%) |
KRAS;GADD45B;NCOA4;...
|
| Toll-like receptor signaling pathway |
-1.61 |
4.25e-2 |
94/104 (90.38%) |
TAB2;MAPK1;IFNA16;...
|
| Cytokine-cytokine receptor interaction |
-1.62 |
4.21e-2 |
246/295 (83.39%) |
TNFRSF11A;CCL4;CSH1;...
|
| Phagosome |
-1.63 |
4.05e-2 |
118/152 (77.63%) |
CLEC4M;TCIRG1;MARCO;...
|
| Hepatitis B |
-1.63 |
4.12e-2 |
151/162 (93.21%) |
TAB2;MAPK1;IFNA16;...
|
| Nicotinate and nicotinamide metabolism |
-1.64 |
4.08e-2 |
25/35 (71.43%) |
NT5E;PNP;AOX1;...
|
| Shigellosis |
-1.67 |
3.34e-2 |
180/246 (73.17%) |
NAIP;PIK3R2;PFN2;...
|
| Proteasome |
-1.67 |
3.48e-2 |
44/46 (95.65%) |
PSMB3;PSMB1;PSMA1;...
|
| Salmonella infection |
-1.67 |
3.54e-2 |
198/249 (79.52%) |
NAIP;PFN2;CASP8;...
|
| Yersinia infection |
-1.67 |
3.65e-2 |
120/137 (87.59%) |
PIK3R2;ARPC5;PIP5K1C;...
|
| Lysosome |
-1.68 |
3.72e-2 |
115/128 (89.84%) |
ARSB;CTSD;SLC11A1;...
|
| Lipid and atherosclerosis |
-1.69 |
3.32e-2 |
190/215 (88.37%) |
TAB2;TANK;MAPK1;...
|
| Prion disease |
-1.70 |
3.33e-2 |
209/273 (76.56%) |
MAPK1;NDUFB11;CAV2;...
|
| Leishmaniasis |
-1.73 |
2.74e-2 |
67/77 (87.01%) |
ITGA4;CYBB;MYD88;...
|
| Osteoclast differentiation |
-1.76 |
1.89e-2 |
117/127 (92.13%) |
TAB2;SOCS3;MAPK1;...
|
| Staphylococcus aureus infection |
-1.78 |
1.87e-2 |
72/95 (75.79%) |
FCGR3B;KRT18;C5AR1;...
|
| Complement and coagulation cascades |
-1.78 |
1.86e-2 |
76/85 (89.41%) |
C1QB;CFH;C8G;...
|
| Neutrophil extracellular trap formation |
-1.79 |
1.91e-2 |
101/189 (53.44%) |
CLCN5;TLR4;AQP9;...
|
| TNF signaling pathway |
-1.80 |
1.73e-2 |
103/112 (91.96%) |
TAB2;SOCS3;MAPK1;...
|
| Pertussis |
-1.81 |
1.61e-2 |
64/76 (84.21%) |
C1QA;IL23A;TRAF6;...
|
| Measles |
-1.82 |
1.75e-2 |
133/139 (95.68%) |
PIK3R2;CASP8;CDK4;...
|
| Tuberculosis |
-1.82 |
1.93e-2 |
159/180 (88.33%) |
TLR6;CD209;ATP6V0A2;...
|
| RIG-I-like receptor signaling pathway |
-1.83 |
1.78e-2 |
64/70 (91.43%) |
TANK;IFNA16;AZI2;...
|
| Rheumatoid arthritis |
-1.85 |
1.34e-2 |
78/93 (83.87%) |
TNFRSF11A;ATP6V1G1;FLT1;...
|
| Transcriptional misregulation in cancer |
-1.89 |
6.12e-3 |
158/192 (82.29%) |
FUT8;TAF15;NGFR;...
|
| IL-17 signaling pathway |
-1.91 |
5.35e-3 |
84/94 (89.36%) |
FADD;MMP13;TRAF5;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.99 |
4.28e-3 |
84/100 (84%) |
IL18RAP;CXCL11;CSF1;...
|
| Coronavirus disease |
-1.99 |
5.35e-3 |
215/232 (92.67%) |
RPL7;C1QA;PIK3R2;...
|
| NOD-like receptor signaling pathway |
-2.02 |
0.00e+0 |
145/181 (80.11%) |
TLR4;VDAC1;TXN;...
|
| Malaria |
-2.03 |
0.00e+0 |
44/50 (88%) |
GYPB;SELE;MYD88;...
|
| Legionellosis |
-2.03 |
0.00e+0 |
51/57 (89.47%) |
MYD88;IL1B;SAR1B;...
|
